132 related articles for article (PubMed ID: 23020291)
1. Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians.
Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
Cancer Invest; 2012 Nov; 30(9):630-6. PubMed ID: 23020291
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between Cyclin D1 gene G870A polymorphism and esophageal cancer: evidence from a meta-analysis.
Cai W; Wang ZT; Zhong J; Zhang Y
Genet Mol Res; 2013 Apr; 12(4):6636-45. PubMed ID: 23661400
[TBL] [Abstract][Full Text] [Related]
3. CCND1 G870A polymorphism interaction with cigarette smoking increases lung cancer risk: meta-analyses based on 5008 cases and 5214 controls.
Duan YZ; Zhang L; Liu CC; Zhu B; Zhuo WL; Chen ZT
Mol Biol Rep; 2013 Jul; 40(7):4625-35. PubMed ID: 23653001
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.
Chen B; Cao L; Yang P; Zhou Y; Wu XT
Cancer Epidemiol; 2012 Apr; 36(2):106-15. PubMed ID: 21606015
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a meta-analysis.
Li M; Dai W; Zhou H
ScientificWorldJournal; 2013; 2013():689048. PubMed ID: 24222746
[TBL] [Abstract][Full Text] [Related]
7. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
Oncotarget; 2016 Oct; 7(40):66109-66118. PubMed ID: 27623072
[TBL] [Abstract][Full Text] [Related]
8. Association between
Thakur N; Kumari S; Mehrotra R
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361291
[No Abstract] [Full Text] [Related]
9. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
Xie M; Zhao F; Zou X; Jin S; Xiong S
Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies.
Wu Y; Fu H; Zhang H; Huang H; Chen M; Zhang L; Yang H; Qin D
Tumour Biol; 2014 Jul; 35(7):6913-8. PubMed ID: 24737585
[TBL] [Abstract][Full Text] [Related]
11. Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population.
Zhang J; Li Y; Wang R; Wen D; Sarbia M; Kuang G; Wu M; Wei L; He M; Zhang L; Wang S
Int J Cancer; 2003 Jun; 105(2):281-4. PubMed ID: 12673692
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
[TBL] [Abstract][Full Text] [Related]
13. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
[TBL] [Abstract][Full Text] [Related]
14. The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.
Zhou C; An H; Hu M; Liu Q; Geng P; Xu J; Sun B; Liu C
Tumour Biol; 2013 Dec; 34(6):3831-7. PubMed ID: 23873109
[TBL] [Abstract][Full Text] [Related]
15. The CCND1 G870A polymorphism and susceptibility to bladder cancer.
Li J; Luo F; Zhang H; Li L; Xu Y
Tumour Biol; 2014 Jan; 35(1):171-7. PubMed ID: 23893383
[TBL] [Abstract][Full Text] [Related]
16. The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations.
Zhang LQ; Huang XE; Wang J; Shang JQ; Bai J; Liu FY; Guan X; Zhou JN
Asian Pac J Cancer Prev; 2011; 12(1):81-5. PubMed ID: 21517236
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
Casson AG; Zheng Z; Evans SC; Geldenhuys L; van Zanten SV; Veugelers PJ; Porter GA; Guernsey DL
Cancer; 2005 Aug; 104(4):730-9. PubMed ID: 15971196
[TBL] [Abstract][Full Text] [Related]
18. Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis.
Wang L; Wang Z; Gao X; Li X; Sun X; Liu C
Tumour Biol; 2014 Feb; 35(2):1149-55. PubMed ID: 24186074
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer.
Yuan L; Gu X; Shao J; Wang M; Wang M; Zhu Q; Zhang Z
DNA Cell Biol; 2010 Oct; 29(10):611-7. PubMed ID: 20575692
[TBL] [Abstract][Full Text] [Related]
20. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
Hu YY; Zheng R; Guo C; Niu YM
Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
